EUVIMEDEUVIMED entdecken
LeitlinieÜbersichtsarbeitOpen Access · CC BY 4.0

International Guideline on the Diagnosis, Treatment, and Monitoring of Long‐Chain Fatty Acid Oxidation Disorders ( LC ‐ FAOD )

Sarah C Grünert iD, Kaustuv Bhattacharya iD, Daniela Karall iD, Mirjam Langeveld iD, Fran Rohr, Gepke Visser, Jerry Vockley iD, Aileen Kenneson iD, Rani H Singh iD, Ute Spiekerkoetter iD, International LC‐FAOD Guideline Workgroup

Journal of Inherited Metabolic Disease · 2026

DOI: 10.1002/jimd.70251 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Sarah C Grünert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Lipid Metabolism, Inborn Errors, Fatty Acids, Mitochondrial Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Society for the Study of Inborn Errors of Metabolism, Emory University's Medical Nutrition Therapy for Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long‐chain fatty acid oxidation disorders (LC‐FAOD) are rare inherited defects of mitochondrial β‐oxidation that impair energy generation during fasting or metabolic stress. Clinical manifestations range from neonatal hypoketotic hypoglycemia and cardiomyopathy to hepatopathy, recurrent rhabdomyolysis, and chronic myopathy. Although newborn screening (NBS) enables early detection, management remains inconsistent due to limited evidence, broadening phenotypic spectrum, and regional practice variation. An international multidisciplinary workgroup of 34 members, including clinicians, nurses, dietitians, and patient representatives, systematically reviewed the literature (1990–2022) using PubMed, Embase, and Web of Science. Evidence was graded using an adapted Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, and consensus was achieved through a modified Delphi–Nominal Group–Delphi methodology, with agreement defined as ≥ 75%. Especially when evidence was low, expert consensus was the basis for this guideline. Recommendations address diagnosis, dietary management, fasting tolerance, use of medium‐chain fat sources, exercise and illness protocols, pregnancy care, and long‐term monitoring. Evidence quality ranged from very low to moderate. Strong consensus was reached for critical clinical interventions. Standardized approaches for diagnostic work‐up, management during metabolic stress, and follow‐up monitoring were developed to promote uniform care across age groups, disease groups, and phenotypic severity. This international guideline integrates available evidence and expert consensus to provide standardized recommendations for diagnosis, treatment and lifelong management of LC‐FAOD. They aim to harmonize clinical practice, improve patient outcomes, and support global implementation of evidence‐based metabolic care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid Metabolism, Inborn ErrorsFatty AcidsMitochondrial DiseasesHumansInfant, NewbornNeonatal ScreeningConsensusOxidation-ReductionFemale

Stichwörter der Autor:innen

consensusdiagnosisdietary managementguidelinelong‐chain fatty acid oxidation disordersnewborn screeningoutcome

Substanzen

Fatty Acids

Autor:innen und Institutionen

  • Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Genetic Metabolic Disorders Service, Sydney Children's Hospital Network, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
  • School of Medicine, University of New South Wales, Sydney, Australia.
  • Trinity School of Medicine, Trinity College Dublin, Dublin, Ireland.
  • Department of Pediatrics, Division of Inherited Metabolic Disorders, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Endocrinology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam, the Netherlands.

ORCID-Profile: Sarah C Grünert, Kaustuv Bhattacharya, Daniela Karall, Mirjam Langeveld, Jerry Vockley, Aileen Kenneson, Rani H Singh, Ute Spiekerkoetter

Förderung

  • Society for the Study of Inborn Errors of Metabolism
  • Emory University's Medical Nutrition Therapy for Prevention

Zitieren

APA

Grünert, S. C., Bhattacharya, K., Karall, D., Langeveld, M., Rohr, F., Visser, G., Vockley, J., Kenneson, A., Singh, R. H., Spiekerkoetter, U., & International LC‐FAOD Guideline Workgroup (2026). International Guideline on the Diagnosis, Treatment, and Monitoring of Long‐Chain Fatty Acid Oxidation Disorders ( LC ‐ FAOD ). Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70251

Vancouver

Grünert SC, Bhattacharya K, Karall D, Langeveld M, Rohr F, Visser G, et al. International Guideline on the Diagnosis, Treatment, and Monitoring of Long‐Chain Fatty Acid Oxidation Disorders ( LC ‐ FAOD ). Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70251

BibTeX
@article{Grnert2026,
  author = {Grünert, Sarah C and Bhattacharya, Kaustuv and Karall, Daniela and Langeveld, Mirjam and Rohr, Fran and Visser, Gepke and Vockley, Jerry and Kenneson, Aileen and Singh, Rani H and Spiekerkoetter, Ute and International LC‐FAOD Guideline Workgroup, International LC‐FAOD Guideline Workgroup},
  title = {International Guideline on the Diagnosis, Treatment, and Monitoring of Long‐Chain Fatty Acid Oxidation Disorders ( LC ‐ FAOD )},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  doi = {10.1002/jimd.70251}
}
Kostenlos starten →